Lannett news: Lannett Receives FDA Approval for Phentermine HCl Capsules, 37.5 mg. Lannatte (LCI) news: NEW YORK -- Broadfin Capital, LLC reported in an SEC filing that it owns 1,441,707 shares or 5.1 percent of the common stock of Lannett Company, Inc. (AMEX: LCI). That more than doubles Broadfin's stake, which was 2.29 percent as of March 31, 2011. The firm's shares are worth $6.78 million at Lannett's Tuesday closing price of $4.70. Lannett, founded in 1942, develops, manufactures, packages, markets and distributes generic pharmaceutical products for a wide range of indications. The company is led Arthur Bedrosian, president and chief executive officer. Broadfin is a New York hedge fund, founded by Kevin Kotler in 2005. He previously worked at Kevin's interest in medical technology goes back to his pre-med days at Furman Selz, UBS, ING, and The Galleon Group. SEC filing: tinyurl.com/3l6po46